Skip to main content
Erschienen in: Infection 6/2012

01.12.2012 | Case Report

Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis

verfasst von: S. J. Taj-Aldeen, A. Falamarzi, A. AlMuzrkchi, J. Guarro

Erschienen in: Infection | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Rhinosinusitis infection due to Saksenaea vasiformis is extremely rare. The present case describes a rhino-orbital infection in a 21-month-old Chadian immunocompetent male child with a 2-month history of excessive tearing from the right eye, followed by swelling of the right upper and lower eye lids, associated with right facial swelling and dark coloration surrounding the lower eye lid. Coronal computed tomography (CT) scan of the paranasal sinuses showed opacification of the right nasal cavities with extension to the orbit. Non-septate fungal hyphae were diagnosed by tissue sections and a Blankophor P fluorescent stain microscopy. The culture grew zygomycetes, S. vasiformis that failed to sporulate on Sabouraud dextrose agar, the organism was sporulated after 1 week on Czapek agar medium, and produced flask-shaped brown pigmented sporangium with lateral rhizoids and hemispherical columella filled with spores. The patient underwent a right functional endoscopic sinus surgery, where debridement of both right maxillary and ethmoid sinuses was done. Treatment with amphotericin B lipid complex was started and continued for 41 days. The patient was clinically doing better with decreased eye and facial swelling, and his erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were decreased to normal values. The patient continued with treatment on posaconazole after his discharge, and his condition resolved without further sequelae. Rhinosinusitis due to mucormycosis should be considered in any patient, even in young children, presenting with progressive rhinosinusitis infection, whether immunocompromised or not. Early diagnosis may lead to a successful treatment and good prognosis.
Literatur
1.
Zurück zum Zitat Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.PubMedCrossRef Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.PubMedCrossRef
2.
Zurück zum Zitat Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia. 1976;68:52–62.PubMedCrossRef Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia. 1976;68:52–62.PubMedCrossRef
3.
Zurück zum Zitat Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses. 2009;52:547–9.PubMedCrossRef Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses. 2009;52:547–9.PubMedCrossRef
4.
Zurück zum Zitat Baradkar VP, Kumar S. Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host. Indian J Dermatol. 2009;54:382–4.PubMedCrossRef Baradkar VP, Kumar S. Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host. Indian J Dermatol. 2009;54:382–4.PubMedCrossRef
5.
Zurück zum Zitat Trotter DJ, Gonis G, Cottrill E, Coombs C. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust. 2008;189:519–20.PubMed Trotter DJ, Gonis G, Cottrill E, Coombs C. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust. 2008;189:519–20.PubMed
6.
Zurück zum Zitat Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis. 2000;30:942–3.PubMedCrossRef Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis. 2000;30:942–3.PubMedCrossRef
7.
Zurück zum Zitat Baradkar VP, Mathur M, Taklikar S, Rathi M, Kumar S. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J Med Microbiol. 2008;26:385–7.PubMedCrossRef Baradkar VP, Mathur M, Taklikar S, Rathi M, Kumar S. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J Med Microbiol. 2008;26:385–7.PubMedCrossRef
8.
Zurück zum Zitat Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses. 2011;54:e599–601.PubMedCrossRef Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses. 2011;54:e599–601.PubMedCrossRef
9.
Zurück zum Zitat Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823–4.PubMed Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823–4.PubMed
10.
Zurück zum Zitat Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714–6.PubMedCrossRef Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714–6.PubMedCrossRef
11.
Zurück zum Zitat Vega W, Orellana M, Zaror L, Gené J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006;162:289–94.PubMedCrossRef Vega W, Orellana M, Zaror L, Gené J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006;162:289–94.PubMedCrossRef
12.
Zurück zum Zitat Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol. 2010;48:4410–6.PubMedCrossRef Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol. 2010;48:4410–6.PubMedCrossRef
13.
Zurück zum Zitat Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRef
14.
Zurück zum Zitat Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.PubMedCrossRef Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.PubMedCrossRef
15.
Zurück zum Zitat Kaushik R, Chander J, Gupta S, Sharma R, Punia RS. Fatal primary cutaneous zygomycosis caused by Saksenaea vasiformis: case report and review of literature. Surg Infect (Larchmt). 2012;13:125–9.CrossRef Kaushik R, Chander J, Gupta S, Sharma R, Punia RS. Fatal primary cutaneous zygomycosis caused by Saksenaea vasiformis: case report and review of literature. Surg Infect (Larchmt). 2012;13:125–9.CrossRef
16.
Zurück zum Zitat Chander J, Kaur J, Attri A, Mohan H. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765–70.PubMed Chander J, Kaur J, Attri A, Mohan H. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765–70.PubMed
17.
Zurück zum Zitat Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust. 2008;189:521–2.PubMed Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust. 2008;189:521–2.PubMed
18.
Zurück zum Zitat Lechevalier P, Hermoso DG, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A, Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol. 2008;46:3169–72.PubMedCrossRef Lechevalier P, Hermoso DG, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A, Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol. 2008;46:3169–72.PubMedCrossRef
19.
Zurück zum Zitat Blanchet D, Dannaoui E, Fior A, Huber F, Couppié P, Salhab N, Hoinard D, Aznar C. Saksenaea vasiformis infection, French Guiana.. Emerg Infect Dis. 2008;14:342–4.PubMedCrossRef Blanchet D, Dannaoui E, Fior A, Huber F, Couppié P, Salhab N, Hoinard D, Aznar C. Saksenaea vasiformis infection, French Guiana.. Emerg Infect Dis. 2008;14:342–4.PubMedCrossRef
20.
Zurück zum Zitat Padmaja IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: necrotising fascitis due to Saksenaea vasiformis. Indian J Med Microbiol. 2006;24:58–60.PubMedCrossRef Padmaja IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: necrotising fascitis due to Saksenaea vasiformis. Indian J Med Microbiol. 2006;24:58–60.PubMedCrossRef
21.
Zurück zum Zitat Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90:ECR39.PubMed Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90:ECR39.PubMed
22.
Zurück zum Zitat Campelo C, de Miguel S, del Palacio A. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetic. Enferm Infecc Microbiol Clin. 2005;23:77. Campelo C, de Miguel S, del Palacio A. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetic. Enferm Infecc Microbiol Clin. 2005;23:77.
23.
Zurück zum Zitat Kaufman L, Padhye AA, Parker S. Rhinocerebral zygomycosis caused by Saksenaea vasiformis. J Med Vet Mycol. 1988;26:237–41.PubMedCrossRef Kaufman L, Padhye AA, Parker S. Rhinocerebral zygomycosis caused by Saksenaea vasiformis. J Med Vet Mycol. 1988;26:237–41.PubMedCrossRef
24.
Zurück zum Zitat Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911–9.PubMedCrossRef Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911–9.PubMedCrossRef
Metadaten
Titel
Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis
verfasst von
S. J. Taj-Aldeen
A. Falamarzi
A. AlMuzrkchi
J. Guarro
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 6/2012
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0338-2

Weitere Artikel der Ausgabe 6/2012

Infection 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.